World
Moderna's COVID-19 vaccine shows promise against Delta variant in lab study
- Data was reported from blood serum from eight participants obtained one week after they received the second dose of the vaccine in an early-stage trial.
Moderna Inc said on Tuesday its COVID-19 vaccine produced neutralizing antibodies against emerging variants, including the delta variant first identified in India, in a lab study.
Data was reported from blood serum from eight participants obtained one week after they received the second dose of the vaccine in an early-stage trial.
Comments
Comments are closed.